Swiss National Bank Vaxcyte, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Swiss National Bank holds 180,600 shares of PCVX stock, worth $16.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

180,600

Previous 181,300 0.39%

Holding current value

$16.5 Million

Previous $13.7 Million 50.62%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$70.52 - $117.12 $49,364 - $81,984	-700 Reduced 0.39%	180,600 $20.6 Million
Q2 2024 Aug 08, 2024	BUY	$60.06 - $78.77 $198,198 - $259,941	3,300 Added 1.85%	181,300 $13.7 Million
Q1 2024 May 07, 2024	BUY	$59.79 - $81.05 $1.8 Million - $2.44 Million	30,100 Added 20.35%	178,000 $12.2 Million
Q4 2023 Feb 06, 2024	SELL	$45.35 - $63.41 $299,310 - $418,506	-6,600 Reduced 4.27%	147,900 $9.29 Million
Q3 2023 Nov 08, 2023	BUY	$46.0 - $53.1 $253,000 - $292,050	5,500 Added 3.69%	154,500 $7.88 Million
Q2 2023 Aug 09, 2023	BUY	$34.66 - $54.07 $1.03 Million - $1.61 Million	29,700 Added 24.9%	149,000 $7.44 Million
Q1 2023 May 10, 2023	SELL	$36.27 - $47.2 $232,128 - $302,080	-6,400 Reduced 5.09%	119,300 $4.47 Million
Q4 2022 Feb 08, 2023	BUY	$20.58 - $47.95 $878,765 - $2.05 Million	42,700 Added 51.45%	125,700 $6.03 Million
Q3 2022 Nov 09, 2022	BUY	$21.69 - $28.53 $73,746 - $97,002	3,400 Added 4.27%	83,000 $1.99 Million
Q2 2022 Aug 09, 2022	BUY	$17.68 - $26.58 $523,328 - $786,768	29,600 Added 59.2%	79,600 $1.73 Million
Q1 2022 May 09, 2022	BUY	$17.46 - $26.36 $71,586 - $108,076	4,100 Added 8.93%	50,000 $1.21 Million
Q4 2021 Feb 08, 2022	BUY	$19.32 - $26.45 $19,320 - $26,450	1,000 Added 2.23%	45,900 $1.09 Million
Q2 2021 Aug 06, 2021	BUY	$16.45 - $24.06 $171,080 - $250,224	10,400 Added 30.14%	44,900 $1.01 Million
Q4 2020 Feb 05, 2021	BUY	$26.57 - $51.74 $916,665 - $1.79 Million	34,500 New	34,500 $917,000

Others Institutions Holding PCVX

# of Institutions

354

Shares Held

122M

Call Options Held

775K

Put Options Held

433K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.42B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Vaxcyte, Inc. Transaction History